Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

14.63USD
11 Jul 2014
Price Change (% chg)

$0.02 (+0.14%)
Prev Close
$14.61
Open
$14.55
Day's High
$14.79
Day's Low
$14.27
Volume
93,384
Avg. Vol
143,738
52-wk High
$18.78
52-wk Low
$4.75

OMER.OQ

Chart for OMER.OQ

About

Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system. The Company develops pharmaceutical and therapeutic approaches to the management of surgical pain and inflammation, vasospasm,... (more)

Overall

Beta: 1.01
Market Cap (Mil.): $496.14
Shares Outstanding (Mil.): 33.91
Dividend: --
Yield (%): --

Financials

  OMER.OQ Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -1.55 -- --
ROI: -173.58 -0.70 18.27
ROE: -- -1.57 19.16
Search Stocks

Eye drug wins first FDA approval for Omeros, shares rise

- Omeros Corp said the U.S. Food and Drug Administration had approved its drug for use in cataract and lens replacement surgeries, the first drug developed by the company to get marketing clearance from the regulator.

02 Jun 2014

UPDATE 2-Eye drug wins first FDA approval for Omeros, shares rise

* Omidria to be used in cataract, lens replacement surgeries

02 Jun 2014

FDA approves Omeros eye drug

June 2 - Omeros Corp said the U.S. Food and Drug Administration approved its drug for use in cataract and lens replacement surgeries.

02 Jun 2014

MARKET PULSE-Google, Ralph Lauren, Lazard, Radian, Cognizant, Omeros

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stock index futures fell on Wednesday. Dow Jones industrial average futures were down 0.10 percent at 15,322, S&P 500 futures were down 0.39 percent at 1,736.9 and Nasdaq 100 futures were down 0.39 percent at 3,438.5.

05 Feb 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $105.10 -0.70
Novartis AG (NOVN.VX) CHF79.60 -0.05
Pfizer Inc. (PFE.N) $30.07 +0.07
Roche Holding Ltd. (ROG.VX) CHF262.70 +0.50
Merck & Co., Inc. (MRK.N) $58.44 -0.14
Bayer AG (BAYGn.DE) €101.15 +0.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.81 +0.11
Eli Lilly and Co (LLY.N) $62.84 +0.31
Abbott Laboratories (ABT.N) $41.30 +0.28

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks